REBIOTIX A FERRING COMPANY

Serial Number 88276773
606

Registration Progress

Application Filed
Jan 25, 2019
Under Examination
Jul 23, 2019
Approved for Publication
May 28, 2019
Published for Opposition
May 28, 2019
Registered

Trademark Image

REBIOTIX A FERRING COMPANY

Basic Information

Serial Number
88276773
Filing Date
January 25, 2019
Published for Opposition
May 28, 2019
Abandonment Date
March 1, 2021
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 1, 2021
Classes
005 042

Rights Holder

REBIOTIX, INC.

03
Address
2660 Patton Road
Roseville, MN 55113

Ownership History

REBIOTIX, INC.

Original Applicant
03
Roseville, MN

REBIOTIX, INC.

Owner at Publication
03
Roseville, MN

Legal Representation

Attorney
Michael T. Hess

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

25 events
Date Code Type Description Documents
Mar 1, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 1, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 9, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 9, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 21, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 21, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 24, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 22, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 22, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 22, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 23, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 28, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 28, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 8, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 18, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 17, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 17, 2019 ALIE A ASSIGNED TO LIE Loading...
Apr 16, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 16, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 16, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 8, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 17, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 29, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders in the fields of gastroenterology, reproductive health, metabolic health, endocrinology; pharmaceutical and biopharmaceutical agents used for the treatment of gastrointestinal, infectious, metabolic, liver, inflammatory and neurological diseases and disorders
Class 042
Medical and scientific research; providing medical and scientific research information in the field of clinical trials

Additional Information

Design Mark
The mark consists of a circle formed from six smaller circles positioned above the "b","I", and "o" of the term "rebiotix", with the term "a ferring company" below "rebiotix".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"COMPANY"